Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Revenue
Annual & quarterly revenue history · segment & region breakdown
HTSUF · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsHisamitsu Pharmaceutical Co., Inc. trailing twelve-month (TTM) revenue is $163B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare HTSUF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Hisamitsu Pharmaceutical Co., Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Hisamitsu Pharmaceutical Co., Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Hisamitsu Pharmaceutical Co., Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HTSUF revenue · 4 questionsHTSUF's trailing twelve-month (TTM) revenue is $163B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Hisamitsu Pharmaceutical Co., Inc. SEC filings · GAAP · Hisamitsu Pharmaceutical Co., Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026